Content area

|
|

Påvirket leverbiokemi hos børn med reumatologiske sygdomme

Forfatter(e)

Helene Mygind Wolsk, Marianne Hørby Jørgensen & Susan Nielsen

BørneUngeKlinikken, Rigshospitalet Ugeskr Læger 2018;180:V06170472

Reference: 
Ugeskr Læger 2018;180:V06170472
Blad nummer: 
Sidetal: 
2-6
Affected liver biochemistry in children with rheumatic diseases

Children with rheumatic diseases often have elevated liver biochemistry. This can be triggered by medical treatment, e.g. methotrexate can induce liver injury ranging from mild to severe. Autoimmune hepatitis and sclerosing cholangitis are also seen in conjunction with rheumatic diseases, and early diagnosis and treatment is crucial to prevent development of cirrhosis and liver transplantation. Macrophage activation syndrome is a rare but important differential diagnosis as it is a potentially fatal complication to systemic rheumatic diseases, causing liver dysfunction and multi-organ failure.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Anette Bygum | 19/05
10 kommentarer
af Hans-Iver G. F.-D Kley | 18/05
1 Kommentar
af Per Bonding | 17/05
1 Kommentar
af Jakob Ramlau | 15/05
1 Kommentar
af Svend Erik Heiselberg | 12/05
1 Kommentar